USPTO serial 88488545
PAREXEL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 14, 2020
- Examiner
- COLTON, BRITTANY
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PAREXEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PAREXEL INTERNATIONAL (MA) CORPORATION
NEWTON, MA, US
Other trademarks owned by PAREXEL INTERNATIONAL (MA) CORPORATION
PAREXEL International Corporation
Newton, MA, US
PAREXEL International Corporation
Newton, MA, US
PAREXEL International Corporation
Newton, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; market analysis; providing business and statistical information and data processing services in the pharmaceutical, biotechnology, medical device, and diagnostics industries | ACTIVE | May 8, 2019 |
| 038 | Computer services, namely, provision of access to a computer network in connection with clinical research and drug development | ACTIVE | May 8, 2019 |
| 042 | Conducting clinical research for others; research and development in the field of pharmaceuticals, biopharmaceuticals, medical devices, and medical diagnostics; clinical research in the field of production of chemicals, pharmaceuticals, medical devices and medical diagnostics; providing interactive web sites featuring technology that enables users to collect, review, analyze and report on clinical research and drug development information; providing temporary use of online non-downloadable software to allow users to collect, review, analyze and report on clinical research and drug development; technical support services, namely, [ installation and remote administration of software, and ] troubleshooting of software problems and hosted software applications, all for use in connection with clinical research and drug development | ACTIVE | May 8, 2019 |
| 045 | Advice and regulatory compliance consulting in the field of pharmaceuticals, biopharmaceuticals, medical devices, and diagnostics; regulatory compliance research in the field of approval, registration and production of chemicals, pharmaceuticals, medical devices, and diagnostics | ACTIVE | May 8, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PAREXEL INTERNATIONAL (MA) CORPORATION
- Other trademarks owned by PAREXEL International Corporation
- Other trademarks owned by PAREXEL International Corporation
- Other trademarks owned by PAREXEL International Corporation
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named PAREXEL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 2, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 2, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 2, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 14, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 17, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 17, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 8, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 10, 2021 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jul 14, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 21, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 19, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 5, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 28, 2019 | NWAP | NEW APPLICATION ENTERED | — |